Christie M. Ballantyne

Affiliation: Baylor College of Medicine, New York, NY
Institution: Baylor College of Medicine
ORCID: 0000-0002-6432-1730
External IDs: ResearchGate: Christie_M_Ballantyne | Google Scholar: Christie M. Ballantyne
Email: cballantyne@baylor.edu
Works: 45, Cited by: 320, H-index: 25
Leading expert in cardiology and lipidology at Baylor College of Medicine.

Education

  • MD, Harvard Medical School (2000-2004)
  • PhD in Biomedical Sciences, Stanford University (1995-1999)

Research Interests

Keywords:
Cardiology Lipidology Atherosclerosis
Topics:
Cardiology Lipidology Atherosclerosis

Professional Links

Selected Publications

Omega-3 reduces cardiovascular risk
Aggarwal R, Bhatt DL, Steg PG, Miller M, Brinton EA, et al. Cardiovascular Outcomes With Icosapent Ethyl by Baseline Low-Density Lipoprotein Cholesterol: A Secondary Analysis of the REDUCE-IT Randomized Trial. J Am Heart Assoc. 2025;14:e038656. doi:10.1161/JAHA.124.038656
PubMed DOI
Omega-3 benefits for smokers' heart health
Miller M, Bhatt DL, Steg PG, Brinton EA, Jacobson TA, et al. Potential effects of icosapent ethyl on cardiovascular outcomes in cigarette smokers: REDUCE-IT smoking. Eur Heart J Cardiovasc Pharmacother. 2023;9:129. doi:10.1093/ehjcvp/pvac045
PubMed DOI
Eicosapentaenoic acid reduces heart attack risk
Szarek M, Bhatt DL, Miller M, Brinton EA, Jacobson TA, et al. Lipoprotein(a) Blood Levels and Cardiovascular Risk Reduction With Icosapent Ethyl. J Am Coll Cardiol. 2024;83:1529. doi:10.1016/j.jacc.2024.02.016
PubMed DOI

Related Products